Shire completes the acquisition of ViroPharma Shire's acquisition of ViroPharma, a fast-growing biopharmaceutical company specializing in rare diseases, represents an excellent strategic choice, capable of significantly enhancing our product portfolio for these diseases. View the press release> Who we are Our history Shire around the world News from Shire Therapeutic areas Products Patient Support Social responsability Working in Shire Contact us Print Share on Twitter Welcome to ShireItalia.it There is a simple goal behind our business: to enable people with conditions that alter the quality of life to lead a better life. We work every day to develop new therapeutic solutions for specific health conditions where our drugs can make a tangible and immediate difference for our patients. We are engaged in the therapeutic areas of neuroscience, rare diseases, gastroenterology and internal medicine for the therapy of diseases which, if not adequately treated, can dramatically impact the lives of patients and their families. Whether it is a treatment for rare and very disabling diseases such as Hunter Syndrome or Fabry's disease, or a treatment for a specific learning disorder such as ADHD, our goal is to identify and make available innovative medicines that respond to unmet needs to date. Our priorities are to improve the availability of our drugs already on the market by facilitating access to today's patients and, through a solid Research and Development strategy, to create the conditions to allow access in the future to ever better therapeutic solutions. Shire Italia SpA, a subsidiary of the multinational biopharmaceutical company Shire Plc, is a member of Farmindustria and Assobiotec. It carries out its activity in numerous therapeutic fields such as rare genetic diseases, hematology, nephrology, gastroenterology and child neuropsychiatry. About the Shire company> © 2021 Shire Italia SPA Viale della Liberazione, 13 20124 Milan VAT number: 05104850481 Tax code: 00643730419 REA number: MI - 2047765 Contact us | Privacy | Terms of use This website is intended for use by persons residing in Italy. Site updated on 7 October 2014